NO931009L - Anvendelse av 7-okso-7h-pyrido(1,2,3-de)(1,4)benzoksacin-6-karbonsyrer og -ester som legemidler - Google Patents

Anvendelse av 7-okso-7h-pyrido(1,2,3-de)(1,4)benzoksacin-6-karbonsyrer og -ester som legemidler

Info

Publication number
NO931009L
NO931009L NO93931009A NO931009A NO931009L NO 931009 L NO931009 L NO 931009L NO 93931009 A NO93931009 A NO 93931009A NO 931009 A NO931009 A NO 931009A NO 931009 L NO931009 L NO 931009L
Authority
NO
Norway
Prior art keywords
benzoxacin
estes
pyrido
pharmaceuticals
oxo
Prior art date
Application number
NO93931009A
Other languages
English (en)
Norwegian (no)
Other versions
NO931009D0 (no
Inventor
Rainer Neumann
Michael Schriewer
Klaus Grohe
Hermann Hagemann
Arnold Paessens
Juergen Reefschlaeger
Gert Streissle
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO931009D0 publication Critical patent/NO931009D0/no
Publication of NO931009L publication Critical patent/NO931009L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Quinoline Compounds (AREA)
NO93931009A 1992-04-02 1993-03-19 Anvendelse av 7-okso-7h-pyrido(1,2,3-de)(1,4)benzoksacin-6-karbonsyrer og -ester som legemidler NO931009L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4210939A DE4210939A1 (de) 1992-04-02 1992-04-02 Verwendung von 7-Oxo-7H-pyrido[1,2,3-de][1,4]benzoxacin-6-carbonsäuren und -estern als Arzneimittel

Publications (2)

Publication Number Publication Date
NO931009D0 NO931009D0 (no) 1993-03-19
NO931009L true NO931009L (no) 1993-10-04

Family

ID=6455791

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931009A NO931009L (no) 1992-04-02 1993-03-19 Anvendelse av 7-okso-7h-pyrido(1,2,3-de)(1,4)benzoksacin-6-karbonsyrer og -ester som legemidler

Country Status (13)

Country Link
EP (1) EP0563733A1 (ja)
JP (1) JPH0616560A (ja)
KR (1) KR930021208A (ja)
CN (1) CN1077886A (ja)
AU (1) AU3569193A (ja)
CA (1) CA2093106A1 (ja)
DE (1) DE4210939A1 (ja)
HU (1) HU9300925D0 (ja)
IL (1) IL105229A0 (ja)
MX (1) MX9301667A (ja)
NO (1) NO931009L (ja)
PL (1) PL298321A1 (ja)
ZA (1) ZA932349B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100333764B1 (ko) * 1999-09-03 2002-04-25 신영균 아크스폿 용접용 보조장치
AR048650A1 (es) * 2004-05-04 2006-05-10 Tibotec Pharm Ltd Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
TW200710091A (en) * 2005-04-11 2007-03-16 Tibotec Pharm Ltd (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
KR20060093321A (ko) * 2006-08-05 2006-08-24 박장용 와이어 송급 장치에서 크레이터를 설정할 수 있는 용접기시스템
CN102260277B (zh) * 2010-05-24 2013-07-24 中国科学院上海药物研究所 新型苯并噁嗪噁唑烷酮类化合物及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623757A1 (de) * 1986-07-15 1988-01-21 Bayer Ag Neue 1,8-verbrueckte 4-chinoloncarbonsaeuren und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
HU9300925D0 (en) 1993-06-28
DE4210939A1 (de) 1993-10-07
PL298321A1 (en) 1993-10-04
CN1077886A (zh) 1993-11-03
JPH0616560A (ja) 1994-01-25
ZA932349B (en) 1994-10-03
IL105229A0 (en) 1993-07-08
NO931009D0 (no) 1993-03-19
CA2093106A1 (en) 1993-10-03
KR930021208A (ko) 1993-11-22
AU3569193A (en) 1993-10-07
MX9301667A (es) 1993-11-01
EP0563733A1 (de) 1993-10-06

Similar Documents

Publication Publication Date Title
NO903925L (no) Fremgangsmaate for fremstilling av 3-(1-substituert-4-piperazinyl)-1h-indazoler samt anvendelse som legemidler.
NO961006L (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
NO984878D0 (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
ATA285187A (de) Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel
NO953367L (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
DE69302863D1 (de) Wässrige Beschichtungszusammensetzung und diese verwendendes Beschichtungsverfahren
NO954767D0 (no) 4-amino-17 delser som C17-20-lyase- og 5
NO931010L (no) Nye 9-fluor-7-okso-7h-pyrido(1,2,3-de)(1,4)benzoksazin-6-karbonsyrer og -estere
NO931009L (no) Anvendelse av 7-okso-7h-pyrido(1,2,3-de)(1,4)benzoksacin-6-karbonsyrer og -ester som legemidler
NO931011D0 (no) 7-okso-7h-pyrido(1,2,3-de)(1,4)benzoksacin-6-karbonsyrer og -estere
NO308251B1 (no) Karbohydratderivater, farmasøytisk blanding inneholdende karbohydratderivater samt anvendelse av samme
FI930722A (fi) Foerfarande foer framstaellning av polymerer som innehaoller ammoniumgrupper
HU9403653D0 (en) New pharmaceutical use of 1,2,3,4,4a,5,10,10a-octahydro-benzo(g) quinoline derivatives
AU7538187A (en) Pyrido (1,8) naphthyridinones and their use as pharmaceuticals
FI934764A0 (fi) Anordning som hindrar krympning av kabelisolering
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
FI932396A0 (fi) Foerfarande foer framstaellning av en dubbelskyddad 2,3-hydroximetylcyklobutanol
FI935116A0 (fi) Anordning avsedd foer byte av spolhuvud som uttnyttjas vid oljeborrning
NO911892D0 (no) Fremgangsmaate for fremstilling og anvendelse som medikamenter av alfa-oksopyrrol(2,3-b)indoleddiksyrer, estere, amider og beslektede analoger.
NO894516L (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
NO924763L (no) Ny fremgangsmaate for fremstilling av 4-amino-5-hexensyre
FI930219A0 (fi) Anvaendning av reaktionsblandningar som gjutbara massor
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
NO960777D0 (no) Anvendelse av N-alkylerte 1,4-dihydropyridin dikarboksylsyreestere som medikamenter
NO164100C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-klor-s-triazolo-(4,3-a)-pyridin-7-carboxyl-syrer.